Yi‐Hsiang Huang
0000-0001-5241-5425
Publication & Citation Trends
Most Cited Works
Publications
813 total
An invasive primary nasal histiocytic sarcoma in a cat
Cited by 0
Semantic Scholar
Protocol for in vivo and in vitro activation of NLRP3 inflammasome in mice using monosodium urate OA
Cited by 5
Semantic Scholar
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study PDF
Cited by 220
OpenAlex
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements PDF
Cited by 299
OpenAlex
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
Cited by 235
OpenAlex
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
Cited by 351
OpenAlex
Research Topics
Liver Disease Diagnosis and Treatment
(339)
Hepatocellular Carcinoma Treatment and Prognosis
(296)
Hepatitis C virus research
(192)
Hepatitis B Virus Studies
(164)
Liver Disease and Transplantation
(127)
Frequent Co-Authors
Affiliations
Ningbo University
Boston University
Hebei Medical University
Jiangnan University
Agency for Science, Technology and Research